Three in four biotech, medtech and health tech companies say the government’s proposed RDTI changes would hit them hard. Some say they might need to leave Australia.
Three in four biotech, medtech and health tech companies say the government’s proposed RDTI changes would hit them hard. Some say they might need to leave Australia.
This content is for paid subscribers only.
Start your free trial nowor purchase a monthly or annual subscription to read.